Aytu BioPharma, Inc.
AYTU · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,562 | -$15,844 | -$17,051 | -$108,779 |
| Dep. & Amort. | $5,377 | $6,725 | $8,815 | $10,146 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $576 | $2,373 | $6,046 | $5,248 |
| Change in WC | -$5,733 | -$4,660 | -$5,799 | -$10,863 |
| Other Non-Cash | $11,405 | $10,018 | $2,860 | $75,425 |
| Operating Cash Flow | -$1,937 | -$1,388 | -$5,129 | -$28,823 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$228 | -$329 | $0 | $0 |
| Net Acquisitions | $0 | $0 | -$5 | -$3,178 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,332 | $0 | -$112 | -$70 |
| Investing Cash Flow | -$2,560 | -$329 | -$117 | -$3,248 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $6,668 | -$1,890 | -$2,346 | -$5,222 |
| Stock Issued | $14,840 | $3,467 | $15,575 | $11,694 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,065 | -$2,839 | -$4,358 | -$4,942 |
| Financing Cash Flow | $15,443 | -$1,262 | $8,871 | $1,530 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10,946 | -$2,979 | $3,625 | -$30,541 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,006 | $22,985 | $19,360 | $49,901 |
| End Cash | $30,952 | $20,006 | $22,985 | $19,360 |
| Free Cash Flow | -$5,165 | -$1,717 | -$5,129 | -$28,823 |